The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

Part II of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRA did not impact CV ...

CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as ...